Results
VUB, ULB, and Sibelga strengthen ties at ‘Energy Transition Day’
VUB, ULB and Sibelga gathered for the 'Energy Transition Day', a milestone in the recent strategic framework agreement between the three partners to accelerate the energy transition in Brussels.
Read more
VUB launches new spin-off: EMAXSIS SRL
We are proud to celebrate the launch of EMAXSIS SRL, a new spin-off born from the EPOWERS research group at Vrije Universiteit Brussel (VUB).
Read more
BIOTALYS (former AGROSAVFE)
Read more
DRIVIN CAR
The ERIS team proudly announces that the DRIVIN CAR consortium has received an EU grant Prof. Devoogdt Nick from the MITH Research Group will coordinate this consortium for VUB.
Read more
TrueFoodS
The ERIS team proudly announces that the TrueFoodS consortium has received an EU grant : Prof. Kim Van der Borght and Dr. Jorge Freddy Milian Gomez from the DIKE Research Group will coordinate this consortium for VUB.
Read more
JA PCM
The ERIS team proudly announces that the JA PCM consortium has received an EU grant Prof. Bart Neyns from the LMMO Research Group will coordinate this consortium for VUB.
Read more
VUB launches InterACT: International postdoctoral fellowships that build bridges between science and policy
InterACT is a postdoctoral fellowship programme designed to equip researchers in translating scientific excellence into meaningful societal and policy-relevant impact.
Read more
ERIS steps into the spotlight with top-scoring Horizon Europe project
The ERIS team has obtained a top-ranking score and a total EU budget of € 2.368.800 for the new postdoctoral programme InterACT.
Read more
iHealthyPath receives grant to enhance pulmonary embolism management
The iHealthyPath project from the VUB Electronics and Informatics (ETRO) department has received a Proof of Concept (PoC) grant from Innoviris.
Read more
VUB and UZ Brussel spin-off Presscuff raises €781,000 and launches new clinical trial
Presscuff develops a new type of endotracheal tube for patients requiring long-term mechanical ventilation. The raised money allows to further validate this medical technology clinically and move into the next phase of growth.
Read more